Financials
Financial year 2025
Apotheek Reynders from Oostende, company number BE0880882041, closed financial year 2025 with a result of € 223,230 after tax. For that financial year Apotheek Reynders recorded a gross margin of € 389,372 and equity of € 63,723. Compared with financial year 2024, the result moved from € 169,212 to € 223,230. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 63,723
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 223,230
▲ 32% vs 2024
Profit after tax over the fiscal year.
€ 249,869
▼ 55% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 217,704 paid out
98 % of the profit went to the shareholders, mostly to Mediwire (50 % of the shares). That is where the money ends up.
People and assets in 2025
1.8
Average over the fiscal year, from the social balance sheet.
€ 91,907
▲ 6% vs 2024
€ 51,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 89,750
▼ 62% vs 2024
€ 16,250 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 454,065
▲ 13% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,259
▲ 86% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 294,984 | € 279,797 | € 324,817 | € 389,372 | ▲ 20% |
| Profit after taxes | € 169,381 | € 140,916 | € 169,212 | € 223,230 | ▲ 32% |
| Equity | € 63,723 | € 63,723 | € 63,723 | € 63,723 | |
| Total debts | € 1,159,952 | € 773,852 | € 1,031,773 | € 860,327 | ▼ 17% |
| Cash | € 661,485 | € 270,912 | € 561,232 | € 249,869 | ▼ 55% |
| Retained profit | € 43,723 | € 43,723 | € 43,723 | € 43,723 | |
| Dividend | € 169,381 | € 138,416 | € 166,212 | € 217,704 | ▲ 31% |
| Bank debt | € 414,750 | € 399,750 | € 234,750 | € 89,750 | ▼ 62% |
| Balance sheet total | € 1,223,674 | € 837,575 | € 1,095,496 | € 924,050 | ▼ 16% |
| Employees (FTE) | 1.3 | 1.7 | 1.8 | 1.8 |
Key figures of Apotheek Reynders, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Reynders?
What happened at Apotheek Reynders in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 223,230 (▲ 32% vs 2024). filed late Source: NBB ↗
- MEDIWIRE BV became a director. NBB
- New establishment in Oostende. KBO
- Start of the company according to the CBE. KBO
In short
From € 169,381 profit in 2022 to € 223,230 profit in 2025.
Paid € 173,249 in corporate taxes since 2022.
Best year ever: 2025, with € 223,230 profit.
On average € 216,300 of value added per employee in 2025.
A new publication or filing at Apotheek Reynders? We notify you, reason included.
Follow Apotheek ReyndersDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Mediwire comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek ReyndersBehind Apotheek Reynders is MEDIWIRE BV. The shares are held by Mediwire (50%).
Directors
According to the 2025 annual accounts
since 2018
Shareholders
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Torhoutsesteenweg 602A
8400 Oostende
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0880.882.041
- VAT number
- BE 0880.882.041
- Registered office
- Torhoutsesteenweg 602A, 8400 Oostende
- Names & denominations
- Apotheek Reynders
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 April 2006
- Peppol
- Active · Active since 30 Aug 2023
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Overige detailhandel in voedingsmiddelen, neg
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Detailhandel in cosmetica en toiletartikelen
Detailhandel in drogisterijartikelen en onderhoudsproducten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Handelsbemiddeling in meubels, huishoudelijke artikelen en ijzerwaren
+6